Fulgent Genetics, Inc. (FLGT): Total Assets
$1.21B
As of 2025-12-31
$1.09B
As of 2026-06-30
-4.3%
3-year compound annual growth
+11.6%
5-year compound annual growth
n/m
10-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $1.21B | -0.5% | 2026-02-27, Balance as of period end |
| 2024-12-31 | $1.22B | -1.2% | 2026-02-27, Balance as of period end |
| 2023-12-31 | $1.24B | -10.9% | 2025-02-28, Balance as of period end |
| 2022-12-31 | $1.39B | +8.4% | 2024-02-28, Balance as of period end |
| 2021-12-31 | $1.28B | +82.6% | 2023-02-28, Balance as of period end |
| 2020-12-31 | $700.46M | +689.2% | 2022-02-28, Balance as of period end |
| 2019-12-31 | $88.76M | +64.7% | 2021-03-08, Balance as of period end |
| 2018-12-31 | $53.90M | -5.7% | 2020-03-13, Balance as of period end |
| 2017-12-31 | $57.18M | -1.5% | 2019-03-22, Balance as of period end |
| 2016-12-31 | $58.04M | +895.2% | 2018-03-20, Balance as of period end |
| 2015-12-31 | $5.83M | n/a | 2017-03-17, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Fulgent Genetics, Inc. (FLGT) | 2025-12-31 | $1.21B | -0.5% |
| BillionToOne, Inc. (BLLN) | 2025-12-31 | $632.65M | +109.4% |
| Castle Biosciences Inc (CSTL) | 2025-12-31 | $578.56M | +8.9% |
| CareDx, Inc. (CDNA) | 2025-12-31 | $413.23M | -15.8% |
| Veracyte, Inc. (VCYT) | 2025-12-31 | $1.41B | +8.2% |
| GRAIL, Inc. (GRAL) | 2025-12-31 | $2.92B | -2.1% |
| Caris Life Sciences, Inc. (CAI) | 2025-12-31 | $1.13B | +227.5% |
| Guardant Health, Inc. (GH) | 2025-12-31 | $2.01B | +35.5% |
| Biodesix Inc (BDSX) | 2025-12-31 | $87.48M | -10.0% |
Compare FLGT, BLLN, CSTL, CDNA side by side · Screen every company in Services-Medical Laboratories ↗